{"version":"1.0","type":"link","title":"Five-Year Survival and Safety of SABR in Patients with Unresectable Locally Advanced Non-Small Cell Lung Cancer unfit for Concurrent Radio-chemotherapy: Focus on Patterns of Local Recurrence from the START-NEW-ERA Non-randomized Phase 2 Trial.","author_name":"Arcidiacono F 외","author_url":"https://prs-insight.online/author/Arcidiacono%20F","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/95008","thumbnail_width":1200,"thumbnail_height":630}